Recommended Daily Oral Dose of Niacinamide
For a patient without liver disease, renal impairment, or allergy, the recommended daily oral dose of niacinamide is 14-16 mg/day for maintenance (16 mg/day for males, 14 mg/day for females), with an upper safe limit of approximately 900 mg/day for adults. 1
Dosing Framework
Standard Maintenance Dosing
The 2022 ESPEN micronutrient guidelines establish clear dietary reference intakes (DRI) for niacin/nicotinamide based on age and sex 1:
- Males >14 years: 16 mg/day
- Females >14 years: 14 mg/day
- Pregnant women: 18 mg/day
- Lactating women: 16 mg/day
These doses represent the baseline nutritional requirement for healthy individuals without deficiency.
Upper Safety Limits
The critical distinction is between nicotinic acid and nicotinamide, as they have different safety profiles 1:
Nicotinamide (niacinamide): Upper limit is 12.5 mg/kg body weight/day, which equals approximately 900 mg/day for adults. This form does NOT cause flushing and has been studied at doses up to 25 mg/kg/day in diabetic patients without adverse effects 1.
Nicotinic acid: Upper limit is only 10 mg/day due to flushing and potential hypotensive episodes, particularly in elderly patients 1.
Clinical Context and Dose Escalation
When Higher Doses May Be Considered
While the question specifies a patient without deficiency or disease, research demonstrates that nicotinamide has been safely used at higher therapeutic doses in specific clinical contexts:
- 500-1000 mg/day: Used in hemodialysis patients for phosphate control, though this caused thrombocytopenia at these doses 2
- 80 mg/kg/day: Tolerated in cancer patients receiving radiotherapy (approximately 5600 mg for a 70 kg patient), though this is far beyond routine supplementation 3
Important Safety Considerations
Adverse effects are dose-dependent 4:
- Below 1500 mg/day: Regular clinical monitoring may not be indicated
- Common side effects at higher doses include GI upset, liver dysfunction, skin rash, and fatigue
- Nicotinamide causes fewer adverse effects than nicotinic acid at equivalent doses 1, 4
Recent evidence on thrombocytopenia: A 2011 study found that nicotinamide at 500-1000 mg/day decreased platelet counts in hemodialysis patients 2, suggesting caution with prolonged use at doses exceeding the 900 mg/day upper limit.
Practical Dosing Algorithm
For your patient without contraindications:
- For general supplementation: Use 14-16 mg/day (standard DRI)
- For suspected subclinical deficiency: Can safely increase up to 900 mg/day
- Stay well below 900 mg/day for chronic daily use to avoid dose-dependent adverse effects
- Monitor for adverse effects if using doses >100 mg/day chronically, particularly GI symptoms, rash, or fatigue
The most conservative and evidence-based approach is to stay within the 14-16 mg/day range unless there is a specific clinical indication for higher doses, given that the upper limit of 900 mg/day represents a safety threshold rather than a therapeutic target 1.